p27 Kip1 controls cytokinesis via the regulation of citron kinase activation

Journal of Clinical Investigation

Volumn 122, Issue 3, 2012, Pages 844-858

  Serres, Murielle P ^a,b,c   Kossatz, Uta ^d   Chi, Yong ^e   Roberts, James M ^e   Malek, Nisar P ^d   Besson, Arnaud ^a,b,c  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CNRS ERL5294   (France)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; PROTEIN P27; RHO FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CITRON; CONTROLLED STUDY; CYTOKINESIS; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; TELOPHASE;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOKINESIS; ENZYME ACTIVATION; FIBROBLASTS; GENOTYPE; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; MITOSIS; MODELS, BIOLOGICAL; POLYPLOIDY; PROTEIN-SERINE-THREONINE KINASES; RHOA GTP-BINDING PROTEIN;

EID: 84857838695     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI60376     Document Type: Article

References (74)

1. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13(12):1501-1512. (Pubitemid 29297917)
2. Besson A, Dowdy SF, Roberts JM. CDK Inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14(2):159-169. (Pubitemid 351189186)
3. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature. 1998;396(6707):177-180. (Pubitemid 28523620)
4. Fero ML, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 1996;85(5):733-744.
5. Kiyokawa H, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell. 1996;85(5):721-732.
6. Nakayama K, et al. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996;85(5):707-720.
7. Porter PL, et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med. 1997;3(2):222-225. (Pubitemid 27064709)
8. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008;8(4):253-267. (Pubitemid 351430863)
9. Garrett-Engele CM, et al. A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet. 2007;3(12):e219.
10. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 2004;18(8):862-876. (Pubitemid 38529656)
11. Nguyen L, et al. p27Kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev. 2006;20(11):1511-1524. (Pubitemid 43830657)
12. Wu FY, et al. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res. 2006;66(4):2162-2172.
13. Denicourt C, Saenz CC, Datnow B, Cui XS, Dowdy SF. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res. 2007;67(19):9238-9243. (Pubitemid 47535911)
14. Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev. 2006;20(1):47-64. (Pubitemid 43042667)
15. Besson A, et al. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev. 2007;21(14):1731-1746. (Pubitemid 47076473)
16. Serres M, Concha C, Daburon V, Gurian-West M, Roberts JM, Besson A. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene. 2011;30(25):2846-2858.
17. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature. 2001;413(6853):323-327. (Pubitemid 32905854)
18. Coats S, Flanagan WM, Nourse J, Roberts JM. Requirements of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 1996;272(5263):877-880.
19. Nakayama K, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 2000;19(9):2069-2081. (Pubitemid 30237582)
20. Nakayama K, et al. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell. 2004;6(5):661-672. (Pubitemid 38579350)
21. Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, Malek NP. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev. 2004;18(21):2602-2607. (Pubitemid 39453099)
22. See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A. Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. Oncogene. 2010;29(12):1720-1731.
23. Cuadrado M, Gutierrez-Martinez P, Swat A, Nebreda AR, Fernandez-Capetillo O. p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage. Cancer Res. 2009;69(22):8726-8732.
24. Payne SR, et al. p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability. Mol Cell Biol. 2008;28(1):258-268.
25. Glotzer M. Animal cell cytokinesis. Annu Rev Cell Dev Biol. 2001;17:351-386. (Pubitemid 33096180)
26. Guizetti J, Gerlich DW. Cytokinetic abscission in animal cells. Semin Cell Dev Biol. 2010;21(9):909-916.
27. Glotzer M. The molecular requirements for cytokinesis. Science. 2005;307(5716):1735-1739. (Pubitemid 40388608)
28. Piekny A, Werner M, Glotzer M. Cytokinesis: welcome to the Rho zone. Trends Cell Biol. 2005;15(12):651-658. (Pubitemid 41713966)
29. Matsumura F. Regulation of myosin II during cytokinesis in higher eukaryotes. Trends Cell Biol. 2005;15(7):371-377. (Pubitemid 40943526)
30. Watanabe S, et al. mDia2 induces the actin scaffold for the contractile ring and stabilizes its position during cytokinesis in NIH 3T3 cells. Mol Biol Cell. 2008;19(5):2328-2338.
31. Di Cunto F, et al. Citron rho-interacting kinase, a novel tissue-specific ser/thr kinase encompassing the Rho-Rac-binding protein Citron. J Biol Chem. 1998;273(45):29706-29711. (Pubitemid 28509981)
32. Madaule P, et al. Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature. 1998;394(6692):491-494. (Pubitemid 28373961)
33. Zhao ZS, Manser E. PAK and other Rho-associated kinases - effectors with surprisingly diverse mechanisms of regulation. Biochem J. 2005;386(pt 2):201-214. (Pubitemid 40343777)
34. Blumenstein L, Ahmadian MR. Models of the cooperative mechanism for Rho effector recognition: implications for RhoA-mediated effector activation. J Biol Chem. 2004;279(51):53419-53426. (Pubitemid 40051846)
35. Madaule P, et al. A novel partner for the GTP-bound forms of rho and rac. FEBS Lett. 1995;377(2):243-248. (Pubitemid 26015076)
36. Madaule P, Furuyashiki T, Eda M, Bito H, Ishizaki T, Narumiya S. Citron, a Rho target that affects contractility during cytokinesis. Microsc Res Tech. 2000;49(2):123-126. (Pubitemid 30304063)
37. Eda M, et al. Rho-dependent transfer of Citronkinase to the cleavage furrow of dividing cells. J Cell Sci. 2001;114(pt 18):3273-3284. (Pubitemid 32998904)
38. Gai M, et al. Citron kinase controls abscission through RhoA and Anillin. Mol Biol Cell. 2011;22(20):3768-3778.
39. Fu Y, Huang J, Wang KS, Zhang X, Han ZG. RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells. Mol Biol Rep. 2011;38(2):693-702.
40. Kamijo K, et al. Dissecting the role of Rho-mediated signaling in contractile ring formation. Mol Biol Cell. 2006;17(1):43-55. (Pubitemid 43049460)
41. Gruneberg U, et al. KIF14 and citron kinase act together to promote efficient cytokinesis. J Cell Biol. 2006;172(3):363-372. (Pubitemid 43187933)
42. Neumann B, et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature. 2010;464(7289):721-727.
43. Naim V, Imarisio S, Di Cunto F, Gatti M, Bonaccorsi S. Drosophila citron kinase is required for the final steps of cytokinesis. Mol Biol Cell. 2004;15(11):5053-5063. (Pubitemid 39392219)
44. Echard A, Hickson GR, Foley E, O'Farrell PH. Terminal cytokinesis events uncovered after an RNAi screen. Curr Biol. 2004;14(18):1685-1693. (Pubitemid 39239368)
45. Shandala T, Gregory SL, Dalton HE, Smallhorn M, Saint R. Citron kinase is an essential effector of the Pbl-activated Rho signalling pathway in Drosophila melanogaster. Development. 2004; 131(20):5053-5063. (Pubitemid 39485362)
46. D'Avino PP, Savoian MS, Glover DM. Mutations in sticky lead to defective organization of the contractile ring during cytokinesis and are enhanced by Rho and suppressed by Rac. J Cell Biol. 2004;166(1):61-71. (Pubitemid 38931917)
47. Di Cunto F, Imarisio S, Camera P, Boitani C, Altruda F, Silengo L. Essential role of citron kinase in cytokinesis of spermatogenic precursors. J Cell Sci. 2002;115(pt 24):4819-4826. (Pubitemid 36054635)
48. Di Cunto F, et al. Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. Neuron. 2000;28(1):115-127.
49. Liu H, Di Cunto F, Imarisio S, Reid LM. Citron kinase is a cell cycle-dependent, nuclear protein required for G2/M transition of hepatocytes. J Biol Chem. 2003;278(4):2541-2548. (Pubitemid 36801331)
50. Yamashiro S, et al. Citron kinase, a Rho-dependent kinase, induces di-phosphorylation of regulatory light chain of myosin II. Mol Biol Cell. 2003;14(5):1745-1756. (Pubitemid 36583529)
51. Montagnoli A, et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 1999;13(9):1181-1189. (Pubitemid 29233148)
52. Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J. 1997;16(17):5334-5344. (Pubitemid 27380141)
53. Skop AR, Liu H, Yates J 3rd, Meyer BJ, Heald R. Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. Science. 2004;305(5680):61-66. (Pubitemid 38869369)
54. Kuo TC, et al. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat Cell Biol. 2011;13(10):1214-1223.
55. Vega FM, Fruhwirth G, Ng T, Ridley AJ. RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol. 2011;193(4):655-665.
56. Hauck L, et al. Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med. 2008;14(3):315-324. (Pubitemid 351347917)
57. Zhang W, Benson DL. Targeting and clustering citron to synapses. Mol Cell Neurosci. 2006;31(1):26-36. (Pubitemid 43049899)
58. Larrea MD, et al. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci U S A. 2009;106(23):9268-9273.
59. Hoshino D, Tomari T, Nagano M, Koshikawa N, Seiki M. A novel protein associated with membranetype 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion. J Biol Chem. 2009;284(40):27315-27326.
60. Papakonstanti EA, Ridley AJ, Vanhaesebroeck B. The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. Embo J. 2007;26(13):3050-3061. (Pubitemid 47057501)
61. Zhong L, Georgia S, Tschen SI, Nakayama K, Bhushan A. Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. J Clin Invest. 2007;117(10):2869-2876. (Pubitemid 47529617)
62. Guidotti JE, Bregerie O, Robert A, Debey P, Brechot C, Desdouets C. Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem. 2003;278(21):19095-19101. (Pubitemid 36799297)
63. Chang Y, Klezovitch O, Walikonis RS, Vasioukhin V, LoTurco JJ. Discs large 5 is required for polarization of citron kinase in mitotic neural precursors. Cell Cycle. 2010;9(10):1990-1997.
64. Camera P, et al. Citron-N is a neuronal Rho-associated protein involved in Golgi organization through actin cytoskeleton regulation. Nat Cell Biol. 2003;5(12):1071-1078. (Pubitemid 37509113)
65. Chang Y, Paramasivam M, Girgenti MJ, Walikonis RS, Bianchi E, LoTurco JJ. RanBPM regulates the progression of neuronal precursors through Mphase at the surface of the neocortical ventricular zone. Dev Neurobiol. 2010;70(1):1-15.
66. Lowery DM, et al. Proteomic screen defines the Polobox domain interactome and identifies Rock2 as a Plk1 substrate. EMBO J. 2007;26(9):2262-2273. (Pubitemid 46685865)
67. Steigemann P, et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell. 2009;136(3):473-484.
68. Conn CW, Hennigan RF, Dai W, Sanchez Y, Stambrook PJ. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian pololike kinase, Plk3. Cancer Res. 2000;60(24):6826-6831. (Pubitemid 32059146)
69. Pohl C, Jentsch S. Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell. 2008;132(5):832-845. (Pubitemid 351312799)
70. Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res. 2008;68(13):5076-5085.
71. Kossatz U, et al. C-terminal phosphorylation controls the stability and function of p27kip1. Embo J. 2006;25(21):5159-5170. (Pubitemid 44658533)
72. Liang J, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol. 2007;9(2):218-224. (Pubitemid 46420865)
73. Lee-Hoeflich S, et al. PPM1H is a p27 phosphatase implicated in trastuzumab resistance. Cancer Discovery. 2011;1:326-337.
74. Spector DL. Isolation of fibroblasts. In: Spector D, Goldman R, Leinwand L, eds. Cells: A Laboratory Manual. New York, New York USA: Cold Spring Harbor Laboratory Press; 1997:4.3-4.7.